US Patent 11098368 ALK and NTRK1 fusion molecules and uses thereof
Patent 11098368 was granted and assigned to Foundation Medicine on August, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11098368 ALK and NTRK1 fusion molecules and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.